Multiplex Molecular Diagnostics
GeneMatrix has been dedicated to the development of multiplex gene amplification technologies, responding to diverse demands and technological trends in the infectious disease diagnostics market. Particularly, we have developed multiplex molecular diagnostic reagents that allow for easy and rapid diagnosis of various infectious diseases through Real-time PCR based multiplex technology. To expand our portfolio, we are actively engaged in various research and development activities.
GeneMatrix’s Molecular Diagnostic Technology
-
- C-Tag™ Platform
Technology - Real-time PCR-based simultaneous multiple gene amplification technology that overcomes the limitations of fluorescence channel analysis
- C-Tag™ Platform
-
- EnCleap™
Technology - PCR technology inhibiting nonspecific amplification products.
- EnCleap™
-
- TriO™
Technology - Targeted gene amplification technology detecting various mutations
- TriO™
-
- RFMP™ Platform
Technology - Genotyping technology analyzing genetic fragments at the Dalton level.
- RFMP™ Platform
Innovative Multiplex Technology
GeneMatrix's multiplex technology is the world's best high-end multiplex technology that maintains high accuracy while identifying multiple genes. In particular, the C-Tag™ technology has been developed through GeneMatrix's more than 20 years of development expertise, enabling the simultaneous diagnosis of 20 different pathogens in a single tube.
Technical Platforms for Rapid Product Development
Simultaneous multiple analysis technology is also used as a foundational technology to develop various molecular diagnostic products in our technical platform. It is applicable to the development of diagnostic technologies for respiratory viruses like influenza, sexually transmitted infections, human papillomavirus, as well as tuberculosis, meningitis, antibiotic resistance, and other infectious diseases. GeneMatrix promotes the advancement of platform technology, expanding development into various diseases.
Development Capabilities
GeneMatrix Molecular Diagnostics Research Center is conducting research and development based on its expertise and development infrastructure in multiplex technology. To maintain the cutting edge of diagnostic technology, continuous research is being conducted on each panel, and we are building specialized development capabilities such as expert scientific personnel -using robust database analysis methodologies to improve product performance and quality.
